Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.94
+0.02 (0.01%)
AAPL  267.80
-5.15 (-1.89%)
AMD  199.29
-4.39 (-2.16%)
BAC  49.38
-2.91 (-5.57%)
GOOG  307.29
+0.14 (0.05%)
META  642.59
-14.42 (-2.19%)
MSFT  394.96
-6.76 (-1.68%)
NVDA  180.07
-4.82 (-2.61%)
ORCL  144.33
-5.98 (-3.98%)
TSLA  400.05
-8.53 (-2.09%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.